References
- Abhyankar A, Ham M, Moss AC (2013) Meta-analysis: the impact of disease activity at conception on disease activity during pregnancy in patients with inflammatory bowel disease. Alimentary Pharmacol Ther 38:460–466.
https://doi.org/10.1111/apt.12417 - Alijotas-Reig J, Esteve-Valverde E, Anunciación-Llunell A et al. (2022) Pathogenesis, diagnosis and management of obstetric antiphospholipid syndrome: a comprehensive review. J Clin Med 11:675.
https://doi.org/10.3390/jcm11030675 - Ambati A, Knight JS, Zuo Y (2023) Antiphospholipid syndrome management: a 2023 update and practical algorithm-based approach. Curr Opin Rheumatol 35:149–160.
https://doi.org/10.1097/BOR.0000000000000932 - Ameer MA, Chaudhry H, Mushtaq J et al. (2022) An overview of systemic lupus erythematosus (SLE) pathogenesis, classification, and management. Cureus 14:e30330.
https://doi.org/10.7759/cureus.30330 - Andrawus M, Sharvit L, Atzmon G (2022) Epigenetics and pregnancy: conditional snapshot or rolling event. Int J Mol Sci 23:12698.
https://doi.org/10.3390/ijms232012698 - Antonelli A, Wartofsky L, Miccoli P (2021) Editorial: levothyroxine therapy in patients with hypothyroidism. Front Endocrinol 12:734895.
https://doi.org/10.3389/fendo.2021.734895 - Baer AN, Witter FR, Petri M (2011) Lupus and pregnancy. Obstet Gynecol Surv 66:639–653.
https://doi.org/10.1097/OGX.0b013e318239e1ee - Ballester Ferré MP, Boscá-Watts MM, Mínguez Pérez M (2018) Enfermedad de Crohn. Med Clín 151:26–33.
https://doi.org/10.1016/j.medcli.2017.10.036 - Bandoli G, Singh N, Strouse J et al. (2020) Mediation of adverse pregnancy outcomes in autoimmune conditions by pregnancy complications: a mediation analysis of autoimmune conditions and adverse pregnancy outcomes. Arthritis Care Res 72:256–264.
https://doi.org/10.1002/acr.24037 - Barros T, Braga A, Marinho A et al. (2021) Behçet’s disease and pregnancy: a retrospective case-control study. Yale J Biol Med 94:585–592. PMID: 34970095
- Béhin A, Mayer M, Kassis-Makhoul B et al. (2008) Severe neonatal myasthenia due to maternal anti-MuSK antibodies. Neuromuscul Disord 18:443–446.
https://doi.org/10.1016/j.nmd.2008.03.006 - Betran AP, Ye J, Moller AB et al. (2021) Trends and projections of caesarean section rates: global and regional estimates. BMJ Glob Health 6:e005671.
https://doi.org/10.1136/bmjgh-2021-005671 - Bitsadze V, Yakubova F, Khizroeva J et al. (2024) Catastrophic antiphospholipid syndrome. Int J Mol Sci 25:668.
https://doi.org/10.3390/ijms25010668 - Bourque PR, Breiner A (2018) Myasthenia gravis. Can Med Assoc J 190:E1141–E1141.
https://doi.org/10.1503/cmaj.180656 - Bruner LP, White AM, Proksell S (2023) Inflammatory bowel disease. Prim Care 50:411–427.
https://doi.org/10.1016/j.pop.2023.03.009 - Calderwood AH, Kane SV (2004) IBD and pregnancy. MedGenMed 6:14. PMID: 15775841
- Calimag APP, Chlebek S, Lerma EV et al. (2023) Diabetic ketoacidosis. Dis Mon 69:101418.
https://doi.org/10.1016/j.disamonth.2022.101418 - Castiglione F, Pignata S, Morace F et al. (1996) Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol 28:199–204. PMID: 8842834
- Caturegli P, De Remigis A, Rose NR (2014) Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev 13:391–397.
https://doi.org/10.1016/j.autrev.2014.01.007 - Cervera R, Serrano R, Pons-Estel GJ et al. (2015) Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 74:1011–1018.
https://doi.org/10.1136/annrheumdis-2013-204838 - Chang KJ, Seow KM, Chen KH (2023) Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition. Int J Environ Res Public Health 20:2994.
https://doi.org/10.3390/ijerph20042994 - Chauhan K, Jandu JS, Brent LH et al. (2024) Rheumatoid arthritis. StatPearls [Internet], Treasure Island (FL).
- Ciplea AI, Langer-Gould A, Stahl A et al. (2020) Safety of potential breast milk exposure to IFN-β or glatiramer acetate. Neurol Neuroimmunol Neuroinflamm 7:e757.
https://doi.org/10.1212/NXI.0000000000000757 - Comarmond C, Saadoun D, Nizard J et al. (2020) Pregnancy issues in Takayasu arteritis. Semin Arthritis Rheum 50:911–914.
https://doi.org/10.1016/j.semarthrit.2020.08.001 - Confavreux C, Hutchinson M, Hours MM et al. (1998) Rate of pregnancy-related relapse in multiple sclerosis. N Engl J Med 339:285–291.
https://doi.org/10.1056/NEJM199807303390501 - Costa RV, Simões C, Correia L et al. (2022) Inflammatory bowel disease and pregnancy: is it a marker for adverse outcomes? Rev Bras Ginecol Obstet 44:915–924.
https://doi.org/10.1055/s-0042-1756149 - Côté JM, Meunier RS, Tremblay JA et al. (2018) Henoch-Schonlein purpura in pregnancy: a case report. Obstet Med 11:195–197.
https://doi.org/10.1177/1753495X17745391 - da Fonseca EB, Damião R, Moreira DA (2020) Preterm birth prevention. Best Pract Res Clin Obstet Gynaecol 69:40–49.
https://doi.org/10.1016/j.bpobgyn.2020.09.003 - Damian L, Pamfil C, Fodor M et al. (2018) Polyarteritis nodosa in pregnancy. Ochsner J 18:94–97.
https://doi.org/10.1043/TOJ-17-0025 - Dao KH, Bermas BL (2022) Systemic lupus erythematosus management in pregnancy. Int J Womens Health 14:199–211.
https://doi.org/10.2147/IJWH.S282604 - Decallonne B, Bartholomé E, Delvaux V et al. (2018) Thyroid disorders in alemtuzumab-treated multiple sclerosis patients: a Belgian consensus on diagnosis and management. Acta Neurol Belg 118:153–159.
https://doi.org/10.1007/s13760-018-0883-2 - Depla AL, De Wit L, Steenhuis TJ et al. (2021) Effect of maternal diabetes on fetal heart function on echocardiography: systematic review and meta-analysis. Ultrasound Obstet Gynecol 57:539–550.
https://doi.org/10.1002/uog.22163 - Desoye G, Herrera E (2021) Adipose tissue development and lipid metabolism in the human fetus: The 2020 perspective focusing on maternal diabetes and obesity. Prog Lipid Res 81:101082.
https://doi.org/10.1016/j.plipres.2020.101082 - D’Ippolito S, Barbaro G, Paciullo C et al. (2023) Antiphospholipid syndrome in pregnancy: new and old pathogenetic mechanisms. Int J Mol Sci 24:3195.
https://doi.org/10.3390/ijms24043195 - Dobson R, Giovannoni G (2019) Multiple sclerosis – a review. Eur J Neurol 26:27–40.
https://doi.org/10.1111/ene.13819 - Doria A, Bajocchi G, Tonon M et al. (2008) Pre-pregnancy counselling of patients with vasculitis. Rheumatology 47(Suppl. 3):iii13–iii15.
https://doi.org/10.1093/rheumatology/ken152 - Ducci RD, Lorenzoni PJ, Kay CS et al. (2017) Clinical follow-up of pregnancy in myasthenia gravis patients. Neuromuscul Disord 27:352–357.
https://doi.org/10.1016/j.nmd.2017.01.021 - European Medicines Agency. (2019). Lemtrada SPC.
- Feldmann R, Rieger W, Sator PG et al. (2002) Schönlein-Henoch purpura during pregnancy with successful outcome for mother and newborn. BMC Dermatol 2:1.
https://doi.org/10.1186/1471-5945-2-1 - Foulon A, Chevreau J, Yze C et al. (2020) Maladie chronique inflammatoire de l’intestin et grossesse: de la conception à la naissance. Gynécol Obstét Fertil Sénol 48:514–519.
https://doi.org/10.1016/j.gofs.2020.02.013 - Fujimoto WY (2000) The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 108:9–14.
https://doi.org/10.1016/S0002-9343(00)00337-5 - Gardnerova M, Eymard B, Morel E et al. (1997) The fetal/adult acetylcholine receptor antibody ratio in mothers with myasthenia gravis as a marker for transfer of the disease to the newborn. Neurology 48:50–54.
https://doi.org/10.1212/WNL.48.1.50 - Gatto M, Iaccarino L, Canova M et al. (2012) Pregnancy and vasculitis: a systematic review of the literature. Autoimmun Rev 11:A447–A459.
https://doi.org/10.1016/j.autrev.2011.11.019 - Gilbert J (2017) Thyrotoxicosis – investigation and management. Clin Med 17:274–277.
https://doi.org/10.7861/clinmedicine.17-3-274 - Gillespie KM (2006) Type 1 diabetes: pathogenesis and prevention. Can Med Assoc J 175:165–170.
https://doi.org/10.1503/cmaj.060244 - Gupta B, Hawkins RD (2015) Epigenomics of autoimmune diseases. Immunol Cell Biol 93:271–276.
https://doi.org/10.1038/icb.2015.18 - Gutaj P, Sawicka-Gutaj N, Brązert M et al. (2015) Insulin resistance in pregnancy complicated by type 1 diabetes mellitus. Do we know enough? Ginekol Pol 86:219–223.
https://doi.org/10.17772/gp/2065 - Hakkarainen KM, Juuti R, Burkill S et al. (2020) Pregnancy outcomes after exposure to interferon beta: a register-based cohort study among women with MS in Finland and Sweden. Ther Adv Neurol Disord 13:5628642095107.
https://doi.org/10.1177/1756286420951072 - Hastings MC, Rizk DV, Kiryluk K et al. (2022) IgA vasculitis with nephritis: update of pathogenesis with clinical implications. Pediatr Nephrol 37:719–733.
https://doi.org/10.1007/s00467-021-04950-y - Hehir MK, Silvestri NJ (2018) Generalized myasthenia gravis. Neurol Clin 36:253–260.
https://doi.org/10.1016/j.ncl.2018.01.002 - Hellwig K, Geissbuehler Y, Sabidó M et al. (2020) Pregnancy outcomes in interferon-beta-exposed patients with multiple sclerosis: results from the European Interferon-beta Pregnancy Registry. J Neurol 267:1715–1723.
https://doi.org/10.1007/s00415-020-09762-y - Henson LJ, Afsar S, Davenport L et al. (2020) Pregnancy outcomes in patients treated with leflunomide, the parent compound of the multiple sclerosis drug teriflunomide. Reproduct Toxicol 95:45–50.
https://doi.org/10.1016/j.reprotox.2020.04.073 - Hoff JM, Daltveit AK, Gilhus NE (2004) Asymptomatic myasthenia gravis influences pregnancy and birth. Eur J Neurol 11:559–562.
https://doi.org/10.1111/j.1468-1331.2004.00900.x - Hoff JM, Daltveit AK, Gilhus NE (2007) Myasthenia gravis in pregnancy and birth: identifying risk factors, optimising care. Eur J Neurol 14:38–43.
https://doi.org/10.1111/j.1468-1331.2006.01538.x - Howard T, Ahmad K, Swanson JA et al. (2014) Polyarteritis nodosa. Tech Vasc Intervent Radiol 17:247–251.
https://doi.org/10.1053/j.tvir.2014.11.005 - Huda S, Whittam D, Bhojak M et al. (2019) Neuromyelitis optica spectrum disorders. Clin Med 19:169–176.
https://doi.org/10.7861/clinmedicine.19-2-169 - Hughes B, De Casillas M, Kaminski H (2004) Pathophysiology of myasthenia gravis. Semin Neurol 24:21–30.
https://doi.org/10.1055/s-2004-829585 - Ibarra Barrueta O, García Martín E, López Sánchez P et al. (2023) Biological and immunosuppressive medications in pregnancy, breastfeeding and fertility in immune mediated diseases. Farm Hosp 47:39–49.
https://doi.org/10.1016/j.farma.2022.12.005 - Jennette JC (2013) Overview of the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides. Clin Exp Nephrol 17:603–606.
https://doi.org/10.1007/s10157-013-0869-6 - Johansen CB, Egeberg A, Jimenez-Solem E et al. (2022) Psoriasis and adverse pregnancy outcomes: a nationwide case-control study in 491,274 women in Denmark. JAAD Int 7:146–155.
https://doi.org/10.1016/j.jdin.2022.03.009 - Justiz Vaillant AA, Goyal A, Varacallo M (2024) Systemic lupus erythematosus. StatPearls [Internet], Treasure Island (FL).
- Kilpatrick ES, Rigby AS, Atkin SL (2007) Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes. Diabetes Care 30:707–712.
https://doi.org/10.2337/dc06-1982 - Kimball AB, Guenther L, Kalia S et al. (2021) Pregnancy outcomes in women with moderate-to-severe psoriasis from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). JAMA Dermatol 157:301.
https://doi.org/10.1001/jamadermatol.2020.5595 - Kitching AR, Anders HJ, Basu N et al. (2020) ANCA-associated vasculitis. Nat Rev Dis Primers 6:71.
https://doi.org/10.1038/s41572-020-0204-y - Knight JS, Kanthi Y (2022) Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome. Semin Immunopathol 44:347–362.
https://doi.org/10.1007/s00281-022-00916-w - Lambe M, Bergstrom AV, Johansson ALV et al. (2020) Reproductive patterns and maternal and pregnancy outcomes in women with psoriasis—A population-based study. J Am Acad Dermatol 82:1109–1116.
https://doi.org/10.1016/j.jaad.2019.05.099 - Landi D, Marfia GA (2020) Exposure to natalizumab during pregnancy and lactation is safe – yes. Mult Scler 26:887–889.
https://doi.org/10.1177/1352458520915814 - Lee SY, Pearce EN (2022) Assessment and treatment of thyroid disorders in pregnancy and the postpartum period. Nat Rev Endocrinol 18:158–171.
https://doi.org/10.1038/s41574-021-00604-z - Li R, Ma D, Su YZ et al. (2021) Adverse effects of maternal rheumatoid arthritis during pregnancy on children. Chin Med J 134:1113–1115.
https://doi.org/10.1097/CM9.0000000000001374 - Lindroos JLV, Bjørk MH, Gilhus NE (2024) Transient neonatal myasthenia gravis as a common complication of a rare disease: a systematic review. J Clin Med 13:1136.
https://doi.org/10.3390/jcm13041136 - Maahs DM, West NA, Lawrence JM et al. (2010) Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39:481–497.
https://doi.org/10.1016/j.ecl.2010.05.011 - Makol A, Krause M (2016) Management of rheumatoid arthritis during pregnancy: challenges and solutions. Open Access Rheumatol 23:23–36.
https://doi.org/10.2147/OARRR.S85340 - Massey JM, De Jesus-Acosta C (2014) Pregnancy and myasthenia gravis. Continuum (Minneap Minn) 20:115–127.
https://doi.org/10.1212/01.CON.0000443840.33310.bd - Mathiesen ER, Ringholm L, Damm P (2011) Therapeutic management of type 1 diabetes before and during pregnancy. Expert Opin Pharmacother 12:779–786.
https://doi.org/10.1517/14656566.2011.540388 - McCance DR, Casey C (2019) Type 1 diabetes in pregnancy. Endocrinol Metab Clin North Am 48:495–509.
https://doi.org/10.1016/j.ecl.2019.05.008 - McIver B, Morris JC (1998) The pathogenesis of Graves’ disease. Endocrinol Metab Clin North Am 27:73–89.
https://doi.org/10.1016/S0889-8529(05)70299-1 - Mekinian A, Lachassinne E, Nicaise-Roland P et al. (2013) European registry of babies born to mothers with antiphospholipid syndrome. Ann Rheum Dis 72:217–222.
https://doi.org/10.1136/annrheumdis-2011-201167 - Menter A (2016) Psoriasis and psoriatic arthritis overview. Am J Manag Care 22(8 Suppl.):s216–24. PMID: 27356193
- Mota A, Borrione P, Santiago M (2007) Thyroid acropachy. J Clin Rheumatol 13:360.
https://doi.org/10.1097/RHU.0b013e31815c6ccc - Neuhaus O, Kieseier BC, Hartung HP (2007) Pharmacokinetics and pharmacodynamics of the interferon-betas, glatiramer acetate, and mitoxantrone in multiple sclerosis. J Neurol Sci 259:27–37.
https://doi.org/10.1016/j.jns.2006.05.071 - Nielsen OH, Gubatan JM, Juhl CB et al. (2022) Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 20:74–87.e3.
https://doi.org/10.1016/j.cgh.2020.09.021 - Niks EH, Verrips A, Semmekrot BA et al. (2008) A transient neonatal myasthenic syndrome with anti-MuSK antibodies. Neurology 70:1215–1216.
https://doi.org/10.1212/01.wnl.0000307751.20968.f1 - Nørgaard M, Larsson H, Pedersen L et al. (2010) Rheumatoid arthritis and birth outcomes: a Danish and Swedish nationwide prevalence study. J Intern Med 268:329–337.
https://doi.org/10.1111/j.1365-2796.2010.02239.x - Norwood F, Dhanjal M, Hill M et al. (2014) Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group. J Neurol Neurosurg Psychiatry 85:538–543.
https://doi.org/10.1136/jnnp-2013-305572 - Okwaraji YB, Krasevec J, Bradley E et al. (2024) National, regional, and global estimates of low birthweight in 2020, with trends from 2000: a systematic analysis. Lancet 403:1071–1080.
https://doi.org/10.1016/S0140-6736(23)01198-4 - Ordás I, Eckmann L, Talamini M et al. (2012) Ulcerative colitis. Lancet 380:1606–1619.
https://doi.org/10.1016/S0140-6736(12)60150-0 - Oreja-Guevara C, Wray S, Buffels R et al. (2019) Pregnancy outcomes in patients treated with ocrelizumab. In: Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); 11–13 September 2019. Stockholm, Sweden.
- Pecher AC, Henes M, Henes JC (2022) Optimal management of ANCA-associated vasculitis before and during pregnancy: current perspectives. Arch Gynecol Obstet 308:379–385.
https://doi.org/10.1007/s00404-022-06744-5 - Pedersen N, Bortoli A, Duricova D et al. (2013) The course of inflammatory bowel disease during pregnancy and postpartum: a prospective European ECCO-EpiCom study of 209 pregnant women. Aliment Pharmacol Ther 38:501–512.
https://doi.org/10.1111/apt.12412 - Petri M (2020) Antiphospholipid syndrome. Transl Res 225:70–81.
https://doi.org/10.1016/j.trsl.2020.04.006 - Raharja A, Mahil SK, Barker JN (2021) Psoriasis: a brief overview. Clin Med (Lond) 21:170–173.
https://doi.org/10.7861/clinmed.2021-0257 - Rendon A, Schäkel K (2019) Psoriasis pathogenesis and treatment. Int J Mol Sci 20:1475.
https://doi.org/10.3390/ijms20061475 - Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B et al. (2012) Hypoglycaemia during pregnancy in women with type 1 diabetes. Diabet Med 29:558–566.
https://doi.org/10.1111/j.1464-5491.2012.03604.x - Rizzo T, Metzger BE, Burns WJ et al. (1991) Correlations between antepartum maternal metabolism and intelligence of offspring. N Engl J Med 325:911–916.
https://doi.org/10.1056/NEJM199109263251303 - Roche P, Bouhour F (2021) Myasthenia gravis and pregnancy. Rev Neurol 177:215–219.
https://doi.org/10.1016/j.neurol.2020.09.015 - Ross C, D’Souza R, Pagnoux C (2020) Pregnancy outcomes in systemic vasculitides. Curr Rheumatol Rep 22:63.
https://doi.org/10.1007/s11926-020-00940-5 - Ross DS, Burch HB, Cooper DS et al. (2016) 2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid 26:1343–1421.
https://doi.org/10.1089/thy.2016.0229 - Saadoun D, Bura-Riviere A, Comarmond C et al. (2021) French recommendations for the management of Takayasu’s arteritis. Orphanet J Rare Dis 16(S3):311.
https://doi.org/10.1186/s13023-021-01922-1 - Schaefer-Graf U, Napoli A, Nolan CJ et al. (2018) Diabetes in pregnancy: a new decade of challenges ahead. Diabetologia 61:1012–1021.
https://doi.org/10.1007/s00125-018-4545-y - Sharma A, Stan MN (2019) Thyrotoxicosis: diagnosis and management. Mayo Clin Proc 94:1048–1064.
https://doi.org/10.1016/j.mayocp.2018.10.011 - Shi QG, Wang ZH, Ma XW et al. (2012) Clinical significance of detection of antibodies to fetal and adult acetylcholine receptors in myasthenia gravis. Neurosci Bull 28:469–474.
https://doi.org/10.1007/s12264-012-1256-0 - Shosha E, Pittock SJ, Flanagan E et al. (2017) Neuromyelitis optica spectrum disorders and pregnancy: interactions and management. Mult Scler 23:1808–1817.
https://doi.org/10.1177/1352458517740215 - Shrivastava D, Master A (2020) Fetal growth restriction. J Obstet Gynecol India 70:103–110.
https://doi.org/10.1007/s13224-019-01278-4 - Sibai BM, Viteri OA (2014) Diabetic ketoacidosis in pregnancy. Obstet Gynecol 123:167–178.
https://doi.org/10.1097/AOG.0000000000000060 - Simionescu AA, Danciu BM, Stanescu AMA (2021) State-of-the-art review of pregnancy-related psoriasis. Medicina 57:804.
https://doi.org/10.3390/medicina57080804 - Singh M, Wambua S, Lee SI et al. (2024) Autoimmune diseases and adverse pregnancy outcomes: an umbrella review. BMC Med 22:94.
https://doi.org/10.1186/s12916-024-03309-y - Skef W (2015) Gastrointestinal Behçet’s disease: a review. World J Gastroenterol 21:3801.
https://doi.org/10.3748/wjg.v21.i13.3801 - Smolen JS, Aletaha D, Barton A et al. (2018) Rheumatoid arthritis. Nat Rev Dis Primers 4:18001.
https://doi.org/10.1038/nrdp.2018.1 - Song Y, Huang X, Yu G et al. (2021) Pathogenesis of IgA vasculitis: an up-to-date review. Front Immunol 12:771619.
https://doi.org/10.3389/fimmu.2021.771619 - Tanaka Y (2020) Rheumatoid arthritis. Inflamm Regen 40:20.
https://doi.org/10.1186/s41232-020-00133-8 - Tan Y, Yang S, Liu Q et al. (2022) Pregnancy-related complications in systemic lupus erythematosus. J Autoimmun 132:102864.
https://doi.org/10.1016/j.jaut.2022.102864 - Taylor RAM, Mackie A, Mogra R et al. (2019) Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy. Diabet Med 36:252–255.
https://doi.org/10.1111/dme.13844 - Tektonidou MG, Andreoli L, Limper M et al. (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296–1304.
https://doi.org/10.1136/annrheumdis-2019-215213 - Temple R (2002) Association between outcome of pregnancy and glycaemic control in early pregnancy in type 1 diabetes: population based study. BMJ 325:1275–1276.
https://doi.org/10.1136/bmj.325.7375.1275 - Torp CK, Brüner M, Keller KK et al. (2021) Vasculitis therapy refines vasculitis mechanistic classification. Autoimmun Rev 20:102829.
https://doi.org/10.1016/j.autrev.2021.102829 - Tsurane K, Tanabe S, Miyasaka N et al. (2019) Management of labor and delivery in myasthenia gravis: a new protocol. J Obstet Gynecol Res 45:974–980.
https://doi.org/10.1111/jog.13922 - Tzartos SJ, Efthimiadis A, Morel E et al. (2008) Neonatal myasthenia gravis: antigenic specificities of antibodies in sera from mothers and their infants. Clin Exp Immunol 80:376–380.
https://doi.org/10.1111/j.1365-2249.1990.tb03296.x - Udovcic M, Pena RH, Patham B et al. (2017) Hypothyroidism and the heart. Methodist Debakey Cardiovasc J 13:55.
https://doi.org/10.14797/mdcj-13-2-55 - van der Giessen J, Huang VW, van der Woude CJ (2019) Modulatory effects of pregnancy on inflammatory bowel disease. Clin Transl Gastroenterol 10:e00009.
https://doi.org/10.14309/ctg.0000000000000009 - van Trotsenburg ASP (2020) Management of neonates born to mothers with thyroid dysfunction, and points for attention during pregnancy. Best Pract Res Clin Endocrinol Metab 34:101437.
https://doi.org/10.1016/j.beem.2020.101437 - Vargas-Uricoechea H (2023) Molecular mechanisms in autoimmune thyroid disease. Cells 12:918.
https://doi.org/10.3390/cells12060918 - Varytė G, Arlauskienė A, Ramašauskaitė D (2021) Pregnancy and multiple sclerosis: an update. Curr Opin Obstet Gynecol 33:378–383.
https://doi.org/10.1097/GCO.0000000000000731 - Vena GA, Cassano N, Bellia G et al. (2015) Psoriasis in pregnancy: challenges and solutions. Psoriasis (Auckl) 18:83–95.
https://doi.org/10.2147/PTT.S82975 - Vidal-Jordana A, Montalban X (2017) Multiple sclerosis. Neuroimaging Clin N Am 27:195–204.
https://doi.org/10.1016/j.nic.2016.12.001 - Voskuhl R, Momtazee C (2017) Pregnancy: effect on multiple sclerosis, treatment considerations, and breastfeeding. Neurotherapeutics 14:974–984.
https://doi.org/10.1007/s13311-017-0562-7 - Vukusic S, Hellwig K, Truffinet P (2019) Pregnancy outcomes in female partners of male patients treated with teriflunomide or leflunomide (an in vivo precursor of teriflunomide). In: Abstract (1146) at the ECTRIMS 2019 congress.
- Wang L, Wang F, Gershwin ME (2015) Human autoimmune diseases: a comprehensive update. J Intern Med 278:369–395.
https://doi.org/10.1111/joim.12395 - Weschenfelder F, Herrmann E, Lehmann T et al. (2022) Predictors of a successful vaginal delivery in women with type 1 diabetes: a retrospective analysis of 20 years. Arch Gynecol Obstet 305:1445–1452.
https://doi.org/10.1007/s00404-021-06255-9 - Wilson SA, Stem LA, Bruehlman RD (2021) Hypothyroidism: diagnosis and treatment. Am Fam Physician 103:605–613. PMID: 33983002
- Yamazaki F (2021) Psoriasis: comorbidities. J Dermatol 48:732–740.
https://doi.org/10.1111/1346-8138.15840 - Yang H, McElree C, Roth MP et al. (1993) Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. Gut 34:517–524.
https://doi.org/10.1136/gut.34.4.517 - Zeydan B, Atkinson EJ, Weis DM et al. (2020) Reproductive history and progressive multiple sclerosis risk in women. Brain Commun 2:fcaa185.
https://doi.org/10.1093/braincomms/fcaa185 - Zhang S, Han X, Liu W et al. (2022) Pregnancy in patients with systemic lupus erythematosus: a systematic review. Arch Gynecol Obstet 308:63–71.
https://doi.org/10.1007/s00404-022-06718-7 - Zucchi D, Fischer-Betz R, Tani C (2023) Pregnancy in systemic lupus erythematosus. Best Pract Res Clin Rheumatol 37:101860.
https://doi.org/10.1016/j.berh.2023.101860